Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Maarten Christiaans
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Chemicals & Drugs
Physiology
Concepts & Ideas
Disorders
Living Beings
Anatomy
Sign-in to see full Profile
Network (preview)
67
van Hooff, Johannes
19
van Duijnhoven, Elly
19
Boots, Johannes
14
Nieman, Fred
14
van den Berg-Loonen, Ella
10
Undre, Nasrullah
9
Stolk, Leo
9
Goossens, Valère
8
Blok, Marinus
8
Bruggeman, Cathrien
7
Middeldorp, Jaap
6
Sillekens, Peter
6
Hilbrands, Luuk
6
Kooman, Jeroen
6
Hené, Ronald
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Maarten Christiaans (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: van der Heijden J; de Beer Y; Hoogtanders K; Christiaans M; de Jong G J; Neef C; Stolk L
Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry.
Journal of pharmaceutical and biomedical analysis 2009;50(4):664-70.
-
2009: Billen E V A; Christiaans M H L; van den Berg-Loonen E M
Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
Tissue antigens 2009;74(3):205-12.
-
2009: Aalten Jeroen; Bemelman Frederike J; van den Berg-Loonen Ella M; Claas Frans H; Christiaans Maarten H; de Fijter Johan W; Hepkema Bouke G; Hené Ronald J; van der Heide Jaap J Homan; van Hooff Johannes P; Lardy Neubury M; Lems Simon P; Otten Henderikus G; Weimar Willem; Allebes Wil A; Hoitsma Andries J
Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(8):2559-66.
-
2009: van de Plas Afke; Dackus John; Christiaans Maarten H L; Stolk Leo M L; van Hooff Johannes P; Neef Cees
A pilot study on sublingual administration of tacrolimus.
Transplant international : official journal of the European Society for Organ Transplantation 2009;22(3):358-9.
-
2009: Billen Evy V A; Christiaans Maarten H L; Lee Jarhow; van den Berg-Loonen Ella M
Donor-directed HLA antibodies before and after transplantectomy detected by the luminex single antigen assay.
Transplantation 2009;87(4):563-9.
-
2008: Snoeijs M G J; Buurman W A; Christiaans M H L; van Hooff J P; Goldschmeding R; van Suylen R J; Peutz-Kootstra C J; van Heurn L W E
Histological assessment of preimplantation biopsies may improve selection of kidneys from old donors after cardiac death.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008;8(9):1844-51.
-
2008: Billen E V A; Voorter C E M; Christiaans M H L; van den Berg-Loonen E M
Luminex donor-specific crossmatches.
Tissue antigens 2008;71(6):507-13.
-
2008: van den Berg-Loonen Ella M; Billen Evy V A; Voorter Christina E M; van Heurn L W Ernest; Claas Frans H J; van Hooff Johannes P; Christiaans Maarten H L
Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients.
Transplantation 2008;85(8):1086-90.
-
2008: Gelens Marielle A C J; Christiaans Maarten H L; van Hooff Johannes P
Glucose metabolism before and after conversion from cyclosporine microemulsion to tacrolimus in stable renal recipients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(2):701-6.
-
2008: Cheung Chi Yuen; van der Heijden Jaques; Hoogtanders Karin; Christiaans Maarten; Liu Yan Lun; Chan Yiu Han; Choi Koon Shing; van de Plas Afke; Shek Chi Chung; Chau Ka Foon; Li Chun Sang; van Hooff Johannes; Stolk Leo
Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation.
Transplant international : official journal of the European Society for Organ Transplantation 2008;21(2):140-5.
-
2007: Op den Buijsch Robert A M; van de Plas Afke; Stolk Leo M L; Christiaans Maarten H L; van Hooff Johannes P; Undre Nas A; van Dieijen-Visser Marja P; Bekers Otto
Evaluation of limited sampling strategies for tacrolimus.
European journal of clinical pharmacology 2007;63(11):1039-44.
-
2007: Hoogtanders Karin; van der Heijden Jaques; Stolk Leo Ml; Neef Cees; Christiaans Maarten; van Hooff Johannes
Internal standard selection for the high-performance liquid chromatography tandem mass spectroscopy assay of everolimus in blood.
Therapeutic drug monitoring 2007;29(5):673-4.
-
2007: Op den Buijsch Robert A M; Christiaans Maarten H L; Stolk Leo M L; de Vries Johan E; Cheung Chi Yuen; Undre Nas A; van Hooff Johannes P; van Dieijen-Visser Marja P; Bekers Otto
Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms.
Fundamental & clinical pharmacology 2007;21(4):427-35.
-
2007: van Hooff J P; Christiaans M H L; van Duijnhoven E M
Glucose metabolic disorder after transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(6):1435-6.
-
2007: Snoeijs M G J; Wiermans B; Christiaans M H; van Hooff J P; Timmerman B E; Schurink G W H; Buurman W A; van Heurn L W E
Recipient hemodynamics during non-heart-beating donor kidney transplantation are major predictors of primary nonfunction.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(5):1158-66.
-
2007: van den Ham Eugénie C H; Kooman Jeroen P; Schols Annemie M W J; Nieman Fred H M; Does Joan D; Akkermans Marco A; Janssen Paul P; Gosker Harry R; Ward Kimberly A; MacDonald Jamie H; Christiaans Maarten H L; Leunissen Karel M L; van Hooff Johannes P
The functional, metabolic, and anabolic responses to exercise training in renal transplant and hemodialysis patients.
Transplantation 2007;83(8):1059-68.
-
2007: Hoogtanders Karin; van der Heijden Jaques; Christiaans Maarten; van de Plas Afke; van Hooff Johannes; Stolk Leo
Dried blood spot measurement of tacrolimus is promising for patient monitoring.
Transplantation 2007;83(2):237-8.
-
2006: Gelens Marielle A C J; Christiaans Maarten H L; van Heurn Ernst L W; van den Berg-Loonen Ella P M; Peutz-Kootstra Carine J; van Hooff Johannes P
High rejection rate during calcineurin inhibitor-free and early steroid withdrawal immunosuppression in renal transplantation.
Transplantation 2006;82(9):1221-3.
-
2006: Lenaers Jo I V; Christiaans Maarten H L; Voorter Christina E M; van Hooff Hans P; van den Berg-Loonen Ella M
Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
Transplantation 2006;82(9):1142-7.
-
2006: Aalten Jeroen; Christiaans Maarten H; de Fijter Hans; Hené Ronald; van der Heijde Jaap Homan; Roodnat Joke; Surachno Janto; Hoitsma Andries
The influence of obesity on short- and long-term graft and patient survival after renal transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 2006;19(11):901-7.
-
2006: van Hooff J P; Gelens M; Boots J M; van Duijnhoven E M; Dackus J; Christiaans M H
Preservation of renal function and cardiovascular risk factors.
Transplantation proceedings 2006;38(7):1987-91.
-
2006: Snoeijs M G J; Schaefer S; Christiaans M H; van Hooff J P; van den Berg-Loonen P M; Peutz-Kootstra C J; Buurman W A; van Heurn L W E
Kidney transplantation using elderly non-heart-beating donors: a single-center experience.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2006;6(5 Pt 1):1066-71.
-
2006: Lenaers Jo; Christiaans Maarten; van Heurn Ernst; van Hooff Hans; van den Berg-Loonen Ella
Frequent but late donor-directed antibody formation after kidney transplantectomy within one month after grafting.
Transplantation 2006;81(4):614-9.
-
2006: Christiaans Maarten H L; van Hooff Johannes P
Plasmapheresis and RATG-induced serum sickness.
Transplantation 2006;81(2):296.
-
2006: van den Berg-Loonen Ella M; Terasaki Paul; Kohanof Sam; Christiaans Maarten H L
Longitudinal testing of seventy-six renal allograft patients for HLA antibodies: Maastricht experience.
Clinical transplants 2006;():305-22.
-
2005: Renkens Jeroen J M; Rouflart Margriet M J; Christiaans Maarten H L; van den Berg-Loonen Ella M; van Hooff Johannes P; van Heurn L W Ernest
Outcome of nonheart-beating donor kidneys with prolonged delayed graft function after transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(11):2704-9.
-
2005: van Hooff Johannes P; Christiaans Maarten H L; van Duijnhoven Elly M
Tacrolimus and posttransplant diabetes mellitus in renal transplantation.
Transplantation 2005;79(11):1465-9.
-
2005: Gelens M A C J; Christiaans M H L; v Hooff J P
Do blood pressure and arterial wall properties change after conversion from cyclosporine to tacrolimus?
Transplantation proceedings 2005;37(4):1900-1.
-
2004: van Hooff Johannes P; Christiaans Maarten H L; van Duijnhoven Elly M
Evaluating mechanisms of post-transplant diabetes mellitus.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19 Suppl 6():vi8-vi12.
-
2004: ter Meulen Cornelis G; van Riemsdijk Iza; Hené Ronald J; Christiaans Maarten H L; Borm George F; Corstens Frans H M; van Gelder Teun; Hilbrands Luuk B; Weimar Willem; Hoitsma Andries J
No important influence of limited steroid exposure on bone mass during the first year after renal transplantation: a prospective, randomized, multicenter study.
Transplantation 2004;78(1):101-6.
-
2004: Artz Marika A; Boots Johannes M M; Ligtenberg Gerry; Roodnat Joke I; Christiaans Maarten H L; Vos Pieter F; Moons Philip; Borm George; Hilbrands Luuk B
Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004;4(6):937-45.
-
2004: ter Meulen Cornelis G; van Riemsdijk Iza; Hené Ronald J; Christiaans Maarten H L; Borm George F; van Gelder Teun; Hilbrands Luuk B; Weimar Willem; Hoitsma Andries J
Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004;4(5):803-10.
-
2004: Goossens Valère J; Christiaans Maarten H L; Blok Marinus J; Terporten Peter H W; Sillekens Peter; Lukacsi Angela; Van Hooff Johannes P; Bruggeman Cathrien A
Onset and duration of cytomegalovirus immediate early 1 mRNA expression in the blood of renal transplant recipients.
Journal of medical virology 2004;72(1):94-101.
-
2004: Boots Johannes M M; Christiaans Maarten H L; van Hooff Johannes P
Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk.
Drugs 2004;64(18):2047-73.
-
2003: van Duijnhoven Elly M; Boots Johannes M M; Christiaans Maarten H L; Stolk Leo M L; Undre Nasrullah A; van Hooff Johannes P
Increase in tacrolimus trough levels after steroid withdrawal.
Transplant international : official journal of the European Society for Organ Transplantation 2003;16(10):721-5.
-
2003: Artz Marika A; Boots Johannes M M; Ligtenberg Gerry; Roodnat Joke I; Christiaans Maarten H L; Vos Pieter F; Blom Henk J; Sweep Fred C G J; Demacker Pierre N M; Hilbrands Luuk B
Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus.
Journal of the American Society of Nephrology : JASN 2003;14(7):1880-8.
-
2003: van den Ham Eugénie C H; Kooman Jeroen P; Christiaans Maarten H L; Nieman Fred H M; van Hooff Johannes P
Weight changes after renal transplantation: a comparison between patients on 5-mg maintenance steroid therapy and those on steroid-free immunosuppressive therapy.
Transplant international : official journal of the European Society for Organ Transplantation 2003;16(5):300-6.
-
2003: van Duijnhoven E M; Boots J M M; Christiaans M H L; van Hooff J P
Metabolic aspects of tacrolimus in renal transplantation. Consequences for the choice of an immunosuppressive regimen and for the management of post-transplant diabetes mellitus.
Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2003;55(1):33-42.
-
2003: de Priester Jacobus A; den Boer Jacques A; Christiaans Maarten H L; Kessels Alphons G H; Giele Eelco L W; Hasman Arie; van Hooff Hans P; van Engelshoven Jos M A
Automated quantitative evaluation of diseased and nondiseased renal transplants with MR renography.
Journal of magnetic resonance imaging : JMRI 2003;17(1):95-103.
-
2002: Boots Johannes M M; Christiaans Maarten H L; Van Duijnhoven Elly M; Van Suylen Robert-Jan; Van Hooff Johannes P
Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study.
Transplantation 2002;74(12):1703-9.
-
2002: Boots J M M; Christiaans M H L; Undre N A; van Hooff J P
Pretransplant pharmacokinetics: does it predict the dose of tacrolimus after renal transplantation?
Transplantation proceedings 2002;34(8):3171-2.
-
2002: Artz M A; Boots J M M; Ligtenberg G; Roodnat J I; Christiaans M H L; Hené R J; Blom H J; Demacker P N M; Hilbrands L B
Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels.
Transplantation proceedings 2002;34(5):1793-4.
-
2002: van Duijnhoven Elly M; Christiaans M H L; Boots Johannes M M; van Hooff J P
Evidence that fasting does not significantly affect trough levels of tacrolimus in stable renal transplant recipients.
Transplantation proceedings 2002;34(5):1723-5.
-
2002: Boots Johannes M M; Christiaans M H I; van Duijnhoven E M; van Suylen R-J; van Hooff J P
Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study.
Transplantation proceedings 2002;34(5):1698-9.
-
2002: Boots Johannes M M; van den Ham E C H; Christiaans M H L; van Hooff J P
Risk of adrenal insufficiency with steroid maintenance therapy in renal transplantation.
Transplantation proceedings 2002;34(5):1696-7.
-
2002: Stolk L M L; Van Duijnhoven E M; Christiaans M H L; van Hooff J P
Trough levels of tacrolimus.
Therapeutic drug monitoring 2002;24(4):573; author reply 573-4.
-
2002: van Duijnhoven Elly M; Christiaans Maarten H L; Boots Johannes M M; Goossens Valère J; Undre Nasrullah A; van Hooff Johannes P
A late episode of post-transplant diabetes mellitus during active hepatitis C infection in a renal allograft recipient using tacrolimus.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(1):195-201.
-
2002: Boots Johannes M M; van Duijnhoven Elly M; Christiaans Maarten H L; Wolffenbuttel Bruce H R; van Hooff Johannes P
Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction.
Journal of the American Society of Nephrology : JASN 2002;13(1):221-7.
-
2002: van Duijnhoven Elly M; Christiaans Maarten H L; Boots Johannes M M; Nieman Fred H M; Wolffenbuttel Bruce H R; van Hooff Johannes P
Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression.
Journal of the American Society of Nephrology : JASN 2002;13(1):213-20.
-
2001: Boots J M; van Duijnhoven E M; Christiaans M H; Nieman F H; van Suylen R J; van Hooff J P
Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
Transplant international : official journal of the European Society for Organ Transplantation 2001;14(6):370-83.
-
2001: de Priester J A; Kessels A G; Giele E L; den Boer J A; Christiaans M H; Hasman A; van Engelshoven J M
MR renography by semiautomated image analysis: performance in renal transplant recipients.
Journal of magnetic resonance imaging : JMRI 2001;14(2):134-40.
-
2001: Kooman J P; Christiaans M H; Boots J M; van Der Sande F M; Leunissen K M; van Hooff J P
A comparison between office and ambulatory blood pressure measurements in renal transplant patients with chronic transplant nephropathy.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;37(6):1170-6.
-
2001: Duijnhoven E M; Boots J M; Christiaans M H; Wolffenbuttel B H; Van Hooff J P
Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study.
Journal of the American Society of Nephrology : JASN 2001;12(3):583-8.
-
2000: ter Meulen C G; Hilbrands L B; van Riemsdijk-van Overbeeke I C; Hené R J; Christiaans M H; Hoitsma A J
[Daclizumab and basiliximab: monoclonal mouse-man antibodies with effective immunosuppression without side effects]
Nederlands tijdschrift voor geneeskunde 2000;144(50):2396-400.
-
2000: de Priester J A; den Boer J A; Giele E L; Christiaans M H; Kessels A; Hasman A; van Engelshoven J M
MR renography: an algorithm for calculation and correction of cortical volume averaging in medullary renographs.
Journal of magnetic resonance imaging : JMRI 2000;12(3):453-9.
-
2000: van den Ham E C; Kooman J P; Christiaans M H; Leunissen K M; van Hooff J P
Posttransplantation weight gain is predominantly due to an increase in body fat mass.
Transplantation 2000;70(1):241-2.
-
2000: van den Ham E C; Kooman J P; Christiaans M H; van Hooff J P
Relation between steroid dose, body composition and physical activity in renal transplant patients.
Transplantation 2000;69(8):1591-8.
-
2000: Christiaans M H; Nieman F; van Hooff J P; van den Berg-Loonen E M
Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation.
Transplantation 2000;69(5):917-27.
-
2000: Goossens V J; Blok M J; Christiaans M H; Sillekens P; Middeldorp J M; Bruggeman C A
Early detection of cytomegalovirus in renal transplant recipients: comparison of PCR, NASBA, pp65 antigenemia, and viral culture.
Transplantation proceedings 2000;32(1):155-8.
-
2000: Blok M J; Lautenschlager I; Christiaans M H; Van Hooff J P; Goossens V J; Middeldorp J M; Sillekens P; Höckerstedt K; Bruggeman C A
Sensitive detection of cytomegalovirus infection in transplant recipients using nucleic acid sequence-based amplification.
Transplantation proceedings 2000;32(1):149-51.
-
1999: van Hooff J P; Christiaans M H; van den Berg-Loonen P M
Clinical significance of flow cytometry before and after renal transplantation.
Transplantation proceedings 1999;31(8):3352.
-
1999: van Hooff J P; Christiaans M H
Use of tacrolimus in renal transplantation.
Transplantation proceedings 1999;31(8):3298-9.
-
1999: van Hooff J P; Boots J M; van Duijnhoven E M; Christiaans M H
Dosing and management guidelines for tacrolimus in renal transplant patients.
Transplantation proceedings 1999;31(7A):54S-57S.
-
1999: van Hooff J P; van Duijnhoven E M; Christiaans M H
Tacrolimus and glucose metabolism.
Transplantation proceedings 1999;31(7A):49S-50S.
-
1999: Blok M J; Christiaans M H; Goossens V J; van Hooff J P; Sillekens P; Middeldorp J M; Bruggeman C A
Early detection of human cytomegalovirus infection after kidney transplantation by nucleic acid sequence-based amplification.
Transplantation 1999;67(9):1274-7.
-
1999: van den Ham E C; Kooman J P; Christiaans M H; Nieman F H; Van Kreel B K; Heidendal G A; Van Hooff J P
Body composition in renal transplant patients: bioimpedance analysis compared to isotope dilution, dual energy X-ray absorptiometry, and anthropometry.
Journal of the American Society of Nephrology : JASN 1999;10(5):1067-79.
-
1999: Christiaans M H; van Hooff J P; Nieman F; van den Berg-Loonen E M
HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome.
Transplantation 1999;67(7):1029-35.
-
1999: Blok M J; Lautenschlager I; Christiaans M H; Van Hooff J P; Goossens V J; Middeldorp J M; Sillekens P; Ramon A; Höckerstedt K; Bruggeman C A
Nucleic acid sequence-based amplification: a new technique for monitoring cytomegalovirus infection in transplant recipients.
Transplantation proceedings 1999;31(1-2):308-9.
-
1999: Undre N A; van Hooff J; Christiaans M; Vanrenterghem Y; Donck J; Heeman U; Kohnle M; Zanker B; Land W; Morales J M; Andrés A; Schäfer A; Stevenson P
Low systemic exposure to tacrolimus correlates with acute rejection.
Transplantation proceedings 1999;31(1-2):296-8.
-
1999: Goossens V J; Blok M J; Christiaans M H; van Hooff J P; Sillekens P; Höckerstedt K; Lautenschlager I; Middeldorp J M; Bruggeman C A
Diagnostic value of nucleic-acid-sequence- based amplification for the detection of cytomegalovirus infection in renal and liver transplant recipients.
Intervirology 1999;42(5-6):373-81.
-
1998: Undre N A; van Hooff J; Christiaans M; Vanrenterghem Y; Donck J; Heeman U; Kohnle M; Zanker B; Land W; Morales J M; Andrés A; Schäfer A; Stevenson P
Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation.
Transplantation proceedings 1998;30(4):1299-302.
-
1998: Christiaans M; van Duijnhoven E; Beysens T; Undre N; Schäfer A; van Hooff J
Effect of breakfast on the oral bioavailability of tacrolimus and changes in pharmacokinetics at different times posttransplant in renal transplant recipients.
Transplantation proceedings 1998;30(4):1271-3.
-
1998: van Duijnhoven E; Christiaans M; Undre N; Stevenson P; van Hooff J
The effect of breakfast on the oral bioavailability of tacrolimus in diabetic and nondiabetic patients before transplantation.
Transplantation proceedings 1998;30(4):1268-70.
-
1998: van Duijnhoven E; Christiaans M; Schäfer A; Undre N; van Hooff J
Tacrolimus dosing requirements in diabetic and nondiabetic patients calculated from pretransplantation data.
Transplantation proceedings 1998;30(4):1266-7.
-
1998: Blok M J; Goossens V J; Vanherle S J; Top B; Tacken N; Middeldorp J M; Christiaans M H; van Hooff J P; Bruggeman C A
Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification.
Journal of clinical microbiology 1998;36(5):1341-6.
-
1998: Christiaans M H; Overhof-de Roos R; Nieman F; van Hooff J P; van den Berg-Loonen E M
Donor-specific antibodies after transplantation by flow cytometry: relative change in fluorescence ratio most sensitive risk factor for graft survival.
Transplantation 1998;65(3):427-33.
-
1998: Blok M J; Christiaans M H; Goossens V J; van Hooff J P; Top B; Middeldorp J M; Bruggeman C A
Evaluation of a new method for early detection of active cytomegalovirus infections. A study in kidney transplant recipients.
Transplant international : official journal of the European Society for Organ Transplantation 1998;11 Suppl 1():S107-9.
-
1997: Mayer A D; Dmitrewski J; Squifflet J P; Besse T; Grabensee B; Klein B; Eigler F W; Heemann U; Pichlmayr R; Behrend M; Vanrenterghem Y; Donck J; van Hooff J; Christiaans M; Morales J M; Andres A; Johnson R W; Short C; Buchholz B; Rehmert N; Land W; Schleibner S; Forsythe J L; Talbot D; Pohanka E
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.
Transplantation 1997;64(3):436-43.
-
1996: Christiaans M H; Overhof R; ten Haaft A; Nieman F; van Hooff J P; van den Berg-Loonen E M
No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients.
Transplantation 1996;62(9):1341-7.
-
1996: Kraat Y J; Stals F S; Christiaans M H; Lazzarotto T; Landini M P; Bruggeman C A
IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
Journal of medical virology 1996;48(3):289-94.
-
1995: Christiaans M; Van den Berg-Loonen E; Ten Haaft A; Nieman F; Van Hooff J
Effect of flow cytometry, complement-dependent cytotoxicity, and auto cross match on cadaveric renal transplant outcome.
Transplantation proceedings 1995;27(1):1028-30.
-
1995: Schleibner S; Krauss M; Wagner K; Erhard J; Christiaans M; van Hooff J; Buist L; Mayer D
FK 506 versus cyclosporin in the prevention of renal allograft rejection--European pilot study: six-week results.
Transplant international : official journal of the European Society for Organ Transplantation 1995;8(2):86-90.
-
1994: Kraat Y J; Christiaans M H; Nieman F H; van den Berg-Loonen P M; van Hooff J P; Bruggeman C A
Risk factors for cytomegalovirus infection and disease in renal transplant recipients: HLA-DR7 and triple therapy.
Transplant international : official journal of the European Society for Organ Transplantation 1994;7(5):362-7.
-
1993: Christiaans M H; van den Berg-Loonen P M; Nieman F H; Cohen B; Kootstra G; van Hooff J P
Cadaveric kidney exchange on the basis of HLA-matching is already cost-effective in the first year after grafting.
Transplantation proceedings 1993;25(1 Pt 2):1685-6.
-
1993: Kraat Y J; Christiaans M H; Nieman F H; van den Berg-Loonen P M; van Hooff J P; Bruggeman C A
Increased frequency of CMV infection in HLA-DR7 matched renal allograft recipients.
Lancet 1993;341(8843):494-5.
-
1992: Christiaans M H; van den Berg-Loonen P M; Nieman F H; van Hooff J P
Very low frequency of rejection due to HLA-(A+)B+DQ matching.
Transplantation proceedings 1992;24(6):2441-2.
-
1992: Christiaans M H; Peltenburg H G; Niemann F H; Kootstra G; Lavrijssen A T; van den Berg-Loonen P M; Tiebosch A; Leunissen K M; van Hooff J P
The impact of ischemic lesions in the donor kidney, donor age, recipient age and HLA (A, B, C, DR, DQ) matching on clinical course after kidney grafting.
Transplant international : official journal of the European Society for Organ Transplantation 1992;5 Suppl 1():S627-8.
-
1991: Christiaans M H; van den Berg-Loonen P M; Peltenburg H G; Leunissen K M; van Hooff J P
More favorable clinical course in kidney allograft recipients due to HLA-B+ DR matching.
Transplantation proceedings 1991;23(5):2674.
Sign-in to see more